Results 81 to 90 of about 21,016 (175)
, 2017 Treatment options for vancomycin-resistant enterococci (VRE) bloodstream infection are limited. Studies comparing daptomycin or linezolid in treating VRE bloodstream infection have conflicting results and suggest daptomycin underdosing.
Chuang, Y-C.;Lin, H-Y.;Chen, P-Y.;Lin, C-Y.;Wang, J-T.;Chang, S-C. +1 more
core +1 more source
Canadian Journal of Infectious Diseases and Medical Microbiology, 2012 Due to the emergence of Staphylococcus aureus with reduced vancomycin susceptibility, newer antibiotics, including daptomycin, have been used to treat methicillin-resistant S aureus infections. Daptomycin is a cyclic lipopeptide that is approved to treat
Ryan Yu +4 more
doaj +1 more source
mSphereDaptomycin is a membrane-targeting last-resort antimicrobial therapeutic for the treatment of infections caused by methicillin- and/or vancomycin-resistant Staphylococcus aureus. In the rare event of failed daptomycin therapy, the source of resistance is
Christian D. Freeman +5 more
doaj +1 more source
Daptomycin in vitro hatékonyságának vizsgálata Enterococcus törzsekkel szemben
, 2010 Munkám során a Debreceni Egyetemen izolált 14 VRE és 15 vancomycinnel szemben érzékeny enterococcus törzs daptomycinnel szemben mutatott in vitro érzékenységét E-teszt módszerrel vizsgáltam.
Drabik, Péter Dániel
core
Pharmacokinetics and skin-tissue penetration of daptomycin in rats
, 2015 Kazuaki Matsumoto,1 Masashi Kitaoka,1 Yuko Kuroda,1 Kazuro Ikawa,2 Norifumi Morikawa,2 Junichi Sasaki,3 Osamu Iketani,4 Satoshi Iwata,4 Tetsuya Horino,5 Seiji Hori,5 Junko Kizu1 1Division of Practical Pharmacy, Keio University Faculty of Pharmacy, Tokyo,
Sasaki J +10 more
core
Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus [PDF]
, 2012 Mao Hagihara1, Takumi Umemura1, Takeshi Mori1,2, Hiroshige Mikamo11Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan; 2Division of Pharmaceutical Science, Faculty of Pharmacy, Meijo ...
Hagihara M, Mikamo H, Mori T, Umemura T
core
International Journal of Infectious DiseasesDaptomycin has been used globally since 2003, with a corresponding increase in daptomycin nonsusceptible (DNS) Staphylococcus aureus. In South Korea, daptomycin became available in 2020, but emerging resistance has posed early therapeutic challenges.
Sun Hee Park +3 more
doaj +1 more source
Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus [PDF]
, 2012 Background Daptomycin non-susceptible enterococci (DNSE) are emerging as an important cause of healthcare-associated infection, however little is known about the epidemiology of DNSE.
Sarah J Johnson +9 more
core +1 more source
Bone penetration of daptomycin in diabetic patients with bacterial foot infections
International Journal of Infectious Diseases, 2019 Objectives: Daptomycin has shown clinical efficacy in diabetic foot infections (DFI). However, only limited data are available on its bone penetration in this particular population. The aim of this study was to determine daptomycin bone concentrations in
Antoine Grillon +8 more
doaj +1 more source
, 2022 Introduction. Daptomycin and levofloxacin were tested as monotherapies and in combination against the antibiotic-susceptible S. aureus strain MSSA 1112 in a rabbit meningitis model and the effect of the combination on induction of resistance was ...
Collaud, Alexandra +5 more
core +1 more source